Tilray Brands, Inc. Proceeds from (Repayments of) Short-term Debt
Tilray Brands, Inc. (TLRY) reported Proceeds from (Repayments of) Short-term Debt of $1.59 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfShortTermDebt · last filed 2026-07-28
- Tilray Brands, Inc. proceeds from (repayments of) short-term debt for the quarter ending 2026-05-31 was -$59.00K.
- Tilray Brands, Inc. proceeds from (repayments of) short-term debt for the quarter ending 2026-02-28 was $267.00K.
- Tilray Brands, Inc. proceeds from (repayments of) short-term debt for the quarter ending 2025-11-30 was $382.00K.
- Tilray Brands, Inc. proceeds from (repayments of) short-term debt for the quarter ending 2025-08-31 was $1.00M, a 894.06% increase year-over-year.
- Tilray Brands, Inc. proceeds from (repayments of) short-term debt for fiscal 2026 was $1.59M.
- Tilray Brands, Inc. proceeds from (repayments of) short-term debt for fiscal 2025 was -$10.85M.
- Tilray Brands, Inc. proceeds from (repayments of) short-term debt for fiscal 2024 was -$5.35M, a 201.71% decline from fiscal 2023.
- Tilray Brands, Inc. proceeds from (repayments of) short-term debt for fiscal 2023 was $5.26M, a 44.10% decline from fiscal 2022.
| Period end | Proceeds from (Repayments of) Short-term Debt 3 month | Proceeds from (Repayments of) Short-term Debt 6 month | Proceeds from (Repayments of) Short-term Debt 9 month | Proceeds from (Repayments of) Short-term Debt 12 month |
|---|---|---|---|---|
| 2026-05-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $208.00K derived: sum of 2 quarters · filed 2026-07-28 | $590.00K derived: sum of 3 quarters · filed 2026-07-28 | $1.59M 10-K · filed 2026-07-28 |
| 2026-02-28 | $267.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | $649.00K derived: sum of 2 quarters · filed 2026-04-01 | $1.65M 10-Q · filed 2026-04-01 | -$1.91M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-11-30 | $382.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $1.39M 10-Q · filed 2026-01-08 | -$2.17M derived: sum of 3 quarters · filed 2026-07-28 | -$9.18M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-08-31 | $1.00M 10-Q · filed 2025-10-09 | -$2.56M derived: sum of 2 quarters · filed 2026-07-28 | -$9.57M derived: sum of 3 quarters · filed 2026-07-28 | -$9.95M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-05-31 | -$3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | -$10.57M derived: sum of 2 quarters · filed 2026-07-28 | -$10.95M derived: sum of 3 quarters · filed 2026-07-28 | -$10.85M 10-K · filed 2026-07-28 |
| 2025-02-28 | -$7.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | -$7.39M derived: sum of 2 quarters · filed 2026-04-01 | -$7.29M 10-Q · filed 2026-04-01 | -$4.29M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-11-30 | -$383.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | -$282.00K 10-Q · filed 2026-01-08 | $2.72M derived: sum of 3 quarters · filed 2026-07-28 | -$2.43M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-08-31 | $101.00K 10-Q · filed 2025-10-09 | $3.10M derived: sum of 2 quarters · filed 2026-07-28 | -$2.05M derived: sum of 3 quarters · filed 2026-07-28 | $3.54M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-05-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | -$2.15M derived: sum of 2 quarters · filed 2026-07-28 | $3.44M derived: sum of 3 quarters · filed 2026-07-28 | -$5.35M 10-K · filed 2026-07-28 |
| 2024-02-29 | -$5.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-08 | $435.00K derived: sum of 2 quarters · filed 2025-04-08 | -$8.35M 10-Q · filed 2025-04-08 | -$3.10M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-11-30 | $5.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-10 | -$3.20M 10-Q · filed 2025-01-10 | $2.06M derived: sum of 3 quarters · filed 2025-07-29 | $4.88M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-08-31 | -$8.79M 10-Q · filed 2024-10-10 | -$3.53M derived: sum of 2 quarters · filed 2025-07-29 | -$710.00K derived: sum of 3 quarters · filed 2025-07-29 | -$3.69M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-05-31 | $5.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $8.08M derived: sum of 2 quarters · filed 2025-07-29 | $5.10M derived: sum of 3 quarters · filed 2025-07-29 | $5.26M 10-K · filed 2025-07-29 |
| 2023-02-28 | $2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | -$157.00K derived: sum of 2 quarters · filed 2024-04-09 | $2.00K 10-Q · filed 2024-04-09 | $629.00K derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-11-30 | -$2.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | -$2.82M 10-Q · filed 2024-01-09 | -$2.19M derived: sum of 3 quarters · filed 2024-10-10 | $6.57M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-08-31 | $159.00K 10-Q · filed 2024-10-10 | $786.00K derived: sum of 2 quarters · filed 2024-10-10 | $9.55M derived: sum of 3 quarters · filed 2024-10-10 | $9.08M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-05-31 | $627.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $9.39M derived: sum of 2 quarters · filed 2024-07-30 | $8.92M derived: sum of 3 quarters · filed 2024-07-30 | $9.41M 10-K · filed 2024-07-30 |
| 2022-02-28 | $8.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | $8.29M derived: sum of 2 quarters · filed 2023-04-10 | $8.78M 10-Q · filed 2023-04-10 | |
| 2021-11-30 | -$467.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | $19.00K 10-Q · filed 2023-01-09 | ||
| 2021-08-31 | $486.00K 10-Q · filed 2022-10-07 | |||
| 2021-05-31 | $8.33M 10-K · filed 2023-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |